- Home
- QNRX vs BNBX Comparison
QNRX vs BNBX Comparison
Compare QNRX & BNBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- BNBX
- Stock Information
- Founded
- QNRX 2018
- BNBX 1983
- Country
- QNRX United States
- BNBX United States
- Employees
- QNRX N/A
- BNBX N/A
- Industry
- QNRX Medical/Dental Instruments
- BNBX Other Consumer Services
- Sector
- QNRX Health Care
- BNBX Consumer Discretionary
- Exchange
- QNRX Nasdaq
- BNBX Nasdaq
- Market Cap
- QNRX 4.8M
- BNBX 5.5M
- IPO Year
- QNRX N/A
- BNBX N/A
- Fundamental
- Price
- QNRX $15.56
- BNBX N/A
- Analyst Decision
- QNRX
- BNBX
- Analyst Count
- QNRX 0
- BNBX 0
- Target Price
- QNRX N/A
- BNBX N/A
- AVG Volume (30 Days)
- QNRX 850.8K
- BNBX 1.1M
- Earning Date
- QNRX 11-06-2025
- BNBX 08-14-2025
- Dividend Yield
- QNRX N/A
- BNBX N/A
- EPS Growth
- QNRX N/A
- BNBX N/A
- EPS
- QNRX N/A
- BNBX 211.51
- Revenue
- QNRX N/A
- BNBX $3,743,063.00
- Revenue This Year
- QNRX N/A
- BNBX N/A
- Revenue Next Year
- QNRX N/A
- BNBX N/A
- P/E Ratio
- QNRX N/A
- BNBX $0.02
- Revenue Growth
- QNRX N/A
- BNBX 55.60
- 52 Week Low
- QNRX $5.01
- BNBX $2.13
- 52 Week High
- QNRX $54.95
- BNBX $319.95
- Technical
- Relative Strength Index (RSI)
- QNRX 66.15
- BNBX N/A
- Support Level
- QNRX $12.31
- BNBX N/A
- Resistance Level
- QNRX $41.80
- BNBX N/A
- Average True Range (ATR)
- QNRX 3.40
- BNBX 0.00
- MACD
- QNRX 0.95
- BNBX 0.00
- Stochastic Oscillator
- QNRX 24.75
- BNBX 0.00
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About BNBX Applied DNA Sciences Inc. Common Stock
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.